Creative Medical Technology  Inc. logo

Creative Medical Technology Inc.

CELZ | NASDAQ
Chart Builder DCF Calculator
$1
+$0.03 (+3.53%)
At close: Sep 21, 2026, 4:00 PM ET
$0.99
-$0.01 (-1.00%)
After-hours: Sep 21, 2026, 7:59 PM ET

Market Data

Market Cap
$2.49M
Enterprise Value
$-6.12M
Beta
2.04
Average Volume
6.77M
Shares Outstanding (Diluted)
3.7M
Shares Change YoY
43.45%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US22529Y4089

Price Performance

Price Change 1M
-22.5%
Price Change 3M
-49.2%
Price Change 6M
-46.5%
Price Change YTD
-49.2%
Price Change 1Y
-71.3%
Price Change 3Y
-80.9%
Price Change 5Y
-98.8%
1M CAGR (ann.)
-16.0%
1Y CAGR (ann.)
-73.4%
5Y CAGR (ann.)
-60.2%
All-Time CAGR
-56.5%

Valuation

PE Ratio
-0.50
Forward PE
N/A
PEG Ratio
-0.01
Forward PEG
0.02
PS Ratio
864.52
Forward PS
0.10
PB Ratio
0.30
P/FCF Ratio
-0.44
P/Adj. FCF Ratio
-0.44
P/OCF Ratio
-0.63
EV/Sales
-2,040.18
EV/EBIT
1.32
EV/EBITDA
1.35
EV/FCF
1.04
Earnings Yield
-200.0%
FCF Yield
-227.6%
Adj. FCF Yield
-227.6%

Financial Health

Net Cash
$8.71M
Total Debt
$0
Cash & Short-Term Investments
$8.71M
Total Assets
$9.38M
Current Ratio
12.91
Quick Ratio
12.73
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
0.00
Altman Z-Score
-9.40
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
-1732.4%
Operating Profit Margin
-155932.3%
EBITDA Margin
-202975.0%
Net Profit Margin
-201355.4%
FCF Margin
-196723.9%
Adj. FCF Margin
-196723.9%
SBC / Revenue
0.0%
SBC Impact (per share)
N/A

Returns

Return on Assets
-64.4%
Return on Equity
-86.7%
Return on Invested Capital
-71.9%
Return on Capital Employed
-71.9%
Return on Tangible Assets
-67.0%

Historical Growth (CAGR)

Revenue CAGR 3Y
-65.6%
Revenue CAGR 5Y
-50.8%
Revenue CAGR 10Y
-11.5%
EPS CAGR 3Y
33.6%
EPS CAGR 5Y
51.9%
EPS CAGR 10Y
43.8%
FCF CAGR 3Y
-2.0%
FCF CAGR 5Y
1.1%
FCF CAGR 10Y
-22.3%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
87.0%
Revenue Growth Next 3Y
2951.5%
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Cash Flow

Operating Cash Flow
$-5.9M
Free Cash Flow
$-5.9M
Adj. Free Cash Flow
$-5.9M
FCF Per Share
-$1.59
OCF Per Share
-$1.59
OCF/S Ratio
-196723.9%

Income Statement

Revenue
$3K
Gross Profit
$-29.05K
Operating Income
$-4.68M
EBITDA
$-4.55M
Net Income
$-6.04M
EPS (Diluted)
-$2
Revenue / Employee
$750
Profit / Employee
$-1.51M
Employees
4

© 2026 bestshares.com. All rights reserved.